A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
for Diffuse Large B Cell Lymphoma (DLBCL)
Drug: Glofitamab
Sites in Rockville Centre, New York +6 more locations
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 65 - 80
Code: NCT06765317·Phase 2·Recruiting·Listed Jan 2025